ADILW

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ADILW

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/04/22	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/04/10	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/04/02	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/03/02	09:00	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/02/28	23:30	GlobeNewswire Inc.	Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/02/13	23:15	GlobeNewswire Inc.	Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2024/01/18	22:30	GlobeNewswire Inc.	Adial Announces Appointment of Tony Goodman as Chief Operating Officer	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/12/20	23:00	GlobeNewswire Inc.	Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/11/30	06:05	GlobeNewswire Inc.	Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/11/15	07:02	GlobeNewswire Inc.	Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/31	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/25	21:00	GlobeNewswire Inc.	Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/25	05:30	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/20	21:00	GlobeNewswire Inc.	Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/19	23:30	GlobeNewswire Inc.	Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/10/18	21:00	GlobeNewswire Inc.	Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/09/28	20:00	GlobeNewswire Inc.	Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/09/05	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/08/28	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on Alcoholism	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/08/23	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/08/21	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/08/04	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public Float	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/07/11	21:30	GlobeNewswire Inc.	Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/06/01	22:00	GlobeNewswire Inc.	Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9th	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/05/12	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/05/10	21:30	GlobeNewswire Inc.	Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and Business	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/03/31	05:05	GlobeNewswire Inc.	Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business Update	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/03/21	22:00	GlobeNewswire Inc.	Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder	NASDAQ:ADILW	Adial Pharmaceuticals Inc
2023/03/08	23:00	GlobeNewswire Inc.	Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th	NASDAQ:ADILW	Adial Pharmaceuticals Inc